| Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins W Kong, J Wei, P Abidi, M Lin, S Inaba, C Li, Y Wang, Z Wang, S Si, ... Nature medicine 10 (12), 1344-1351, 2004 | 1733 | 2004 |
| Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression WJ Kong, H Zhang, DQ Song, R Xue, W Zhao, J Wei, YM Wang, N Shan, ... Metabolism 58 (1), 109-119, 2009 | 333 | 2009 |
| MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition L Wang, XJ Jia, HJ Jiang, Y Du, F Yang, SY Si, B Hong Molecular and cellular biology 33 (10), 1956-1964, 2013 | 183 | 2013 |
| Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism Y Wang, JW Shou, XY Li, ZX Zhao, J Fu, CY He, R Feng, C Ma, BY Wen, ... Metabolism 70, 72-84, 2017 | 164 | 2017 |
| DH334, a β-carboline anti-cancer drug, inhibits the CDK activity of budding yeast Y Li, F Liang, W Jiang, F Yu, R Cao, Q Ma, X Dai, J Jiang, Y Wang, S Si Cancer biology & therapy 6 (8), 1204-1210, 2007 | 120 | 2007 |
| Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways Y Wang, Q Qiu, JJ Shen, DD Li, XJ Jiang, SY Si, RG Shao, Z Wang The international journal of biochemistry & cell biology 44 (11), 1813-1824, 2012 | 116 | 2012 |
| A new nucleosidyl-peptide antibiotic, sansanmycin Y Xie, R Chen, S Si, C Sun, H Xu The Journal of antibiotics 60 (2), 158-161, 2007 | 90 | 2007 |
| Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner Y Bao, L Wang, Y Xu, Y Yang, L Wang, S Si, S Cho, B Hong Atherosclerosis 223 (1), 152-159, 2012 | 88 | 2012 |
| Identification of a mutant α1 Na/K-ATPase that pumps but is defective in signal transduction F Lai, N Madan, Q Ye, Q Duan, Z Li, S Wang, S Si, Z Xie Journal of Biological Chemistry 288 (19), 13295-13304, 2013 | 86 | 2013 |
| Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure− activity relationships, and … H Guo, H Shao, Z Yang, S Xue, X Li, Z Liu, X He, J Jiang, Y Zhang, S Si, ... Journal of medicinal chemistry 53 (4), 1819-1829, 2010 | 83 | 2010 |
| Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis C Liu, T Feng, N Zhu, P Liu, X Han, M Chen, X Wang, N Li, Y Li, Y Xu, S Si Scientific reports 5 (1), 1-13, 2015 | 79 | 2015 |
| The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis S Xu, Y Xu, P Liu, S Zhang, H Liu, S Slavin, S Kumar, M Koroleva, J Luo, ... European heart journal 40 (29), 2398-2408, 2019 | 76 | 2019 |
| microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator H Jiang, J Zhang, Y Du, X Jia, F Yang, S Si, L Wang, B Hong Atherosclerosis 243 (2), 523-532, 2015 | 76 | 2015 |
| Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979 I Namatame, H Tomoda, S Si, Y Yamaguchi, R Masuma, S Omura The Journal of antibiotics 52 (1), 1-6, 1999 | 70 | 1999 |
| Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages I NAMATAME, H TOMODA, N TABATA, S SI, S OMURA The Journal of antibiotics 52 (1), 7-12, 1999 | 70 | 1999 |
| Synthesis and biological evaluation of quinoline derivatives as a novel class of broad-spectrum antibacterial agents HG Fu, ZW Li, XX Hu, SY Si, XF You, S Tang, YX Wang, DQ Song Molecules 24 (3), 548, 2019 | 67 | 2019 |
| Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells Y Xu, P Liu, S Xu, M Koroleva, S Zhang, S Si, ZG Jin Scientific reports 7 (1), 1-9, 2017 | 67 | 2017 |
| Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening DH Fu, W Jiang, JT Zheng, GY Zhao, Y Li, H Yi, ZR Li, JD Jiang, KQ Yang, ... Molecular cancer therapeutics 7 (8), 2386-2393, 2008 | 67 | 2008 |
| DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1 J Zhang, Y Li, L Guo, R Cao, P Zhao, W Jiang, Q Ma, H Yi, Z Li, J Jiang, ... Cancer biology & therapy 8 (24), 2374-2383, 2009 | 66 | 2009 |
| Suberanilohydroxamic Acid as a Pharmacological Kruppel‐Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis Y Xu, S Xu, P Liu, M Koroleva, S Zhang, S Si, ZG Jin Journal of the American Heart Association 6 (12), e007134, 2017 | 64 | 2017 |
